Reading Time: < 1 minute
A Feb. 23, 2018 courtroom sketch of former pharmaceutical executive Martin Shkreli. (Photo: Elizabeth Williams, AP)
So-called “pharma bro” Martin Shkreli earned the eternal ire of the public when he was the CEO of a company called Turing Pharmaceuticals, which he had buy up the rights to and jack up the price of life-saving drug Daraprim from $19 to $1,052 a pill. Read More